Skip to content

BioLife Solutions BLFS Free cash flow yield

Free cash flow yield at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.7%+0.1pp
Danaher logo
DanaherDHR
3.9%+0.6pp
Azenta logo
AzentaAZTA
3.8%
LeMaitre Vascular logo
LeMaitre VascularLMAT
3.2%+1.0pp
TEC
Bio-TechneTECH
3.3%+0.9pp
CryoPort, Inc. logo
CryoPort, Inc.CYRX
-5.8%-1.9pp

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on trailing twelve months.

The official record: BioLife Solutions’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's free cash flow yield?
BioLife Solutions (BLFS) reported free cash flow yield of 0.6% in Q3 2024.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.